A rating of 72 puts Sonnet BioTherapeutics Holdings, Inc. (SONN) near the top of the Healthcare sector according to InvestorsObserver. Sonnet BioTherapeutics Holdings, Inc.'s score of 72 means that it ranks higher than 72% of stocks in the sector. In addition, its overall score of 34 ranks it higher than 34% of all stocks.
SONN has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on SONN!